Amlodipine And Valsartan Tablet, Film Coated
Product Images NDC 65862-739

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 65862-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlo Val Fig1)

A line graph illustrating the probability of achieving systolic blood pressure below 140 mmHg at week 8 among different treatment groups. The x-axis represents baseline systolic blood pressure in mmHg (140 to 180), and the y-axis shows the percentage of subjects achieving SBP < 140 mmHg (0 to 100%). Four lines compare Amlodipine and Valsartan Tablets 10 mg/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo.*

FDA Label Image

Package Label-principal Display Panel (5 mg/320 mg Blister Carton (3 x 10 Unit-dose))

Box packaging label for Amlodipine and Valsartan Tablets USP 5 mg/320 mg by Aurobindo Pharma Limited. The label shows a 30 count of 3 x 10 unit-dose film-coated tablets for oral use. Distributed by Aurobindo Pharma USA, Inc., and made in India. NDC 65862-738-03 is visible on the label.*

FDA Label Image

Package Label-principal Display Panel (10 mg/320 mg (30 Tablets Bottle))

Label for Amlodipine and Valsartan Tablets USP 10 mg/320 mg oral film-coated tablets by Aurobindo Pharma Limited. The carton includes dosage strength, quantity of 30 tablets, storage instructions, distribution details for Aurobindo Pharma USA, Inc., and a barcode. Made in India.*

FDA Label Image

Package Label-principal Display Panel (10 mg/320 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Amlodipine and Valsartan Tablets USP 10 mg/320 mg oral film-coated tablets. The label shows a count of 30 unit-dose tablets (3 x 10) and indicates distribution by Aurobindo Pharma USA, Inc. It includes dosage strength and manufacturer information. The label features a teal and blue design with the Aurobindo logo.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure &lt;90 Mmhg At Week 8 (Amlo Val Fig2)

A line graph titled 'Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8,' showing percentage of patients with DBP below 90 mmHg versus baseline DBP (mmHg). Four lines represent results for Amlodipine and Valsartan tablets 10 mg/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, illustrating comparative efficacy in blood pressure reduction.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure &lt;130 Mmhg At Week 8 (Amlo Val Fig3)

A line chart showing the probability of achieving systolic blood pressure under 130 mmHg at Week 8. The x-axis represents baseline systolic blood pressure (mmHg) ranging approximately from 140 to 180, and the y-axis shows the percentage of patients achieving blood pressure under 130 mmHg, from 0% to 100%. Four data series compare Amlodipine and Valsartan Tablets 10 mg/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure &lt;80 Mmhg At Week 8 (Amlo Val Fig4)

A line graph titled 'Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8' showing the percentage of patients achieving DBP below 80 mmHg across baseline DBP values from 95 to 110 mmHg. The graph compares four groups: Amlodipine and valsartan tablets 10 mg/320 mg, valsartan 320 mg, amlodipine 10 mg, and placebo, with respective trend lines and markers.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg (30 Tablets Bottle))

Label for Amlodipine and Valsartan Tablets USP 5 mg/160 mg film-coated tablets by Aurobindo Pharma Limited. It includes dosing information, storage instructions (store at 20° to 25°C), and safety instructions to keep out of reach of children. Distributed by Aurobindo Pharma USA, Inc., the label also notes the product is made in India and contains 30 tablets.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Amlodipine and Valsartan Tablets USP 5 mg/160 mg film-coated tablets. The label indicates unit-dose packaging with 30 tablets (3 x 10). The product is distributed by Aurobindo Pharma USA, Inc. and made in India. The label includes dosage strength prominently in purple highlights and has regulatory text and a barcode.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg Blister Carton (3 x 10 Unit-dose))

A label for Amlodipine and Valsartan Tablets USP, 10 mg/160 mg, film-coated tablets for oral use. The label includes the NDC 65862-739-30, indicates 30 tablets per package, and shows that the product is distributed by Aurobindo Pharma USA, Inc. Made in India. Storage instructions and dosage information references are visible, along with a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (10 mg/160 mg Blister Carton (3 x 10 Unit-dose))

A packaging label for Amlodipine and Valsartan Tablets USP 10 mg/160 mg, film-coated oral tablets. The label shows a 30 count unit-dose blister pack (3 x 10). It is labeled by Aurobindo Pharma Limited and distributed by Aurobindo Pharma USA, Inc. Includes storage instructions and manufacturer information.*

FDA Label Image

Package Label-principal Display Panel (5 mg/320 mg (30 Tablets Bottle))

Amlodipine and Valsartan Tablets USP 5 mg/320 mg film-coated tablet carton label displaying the active ingredient strengths, NDC 65862-738-30, and containing 30 tablets. The label includes storage instructions at 20° to 25°C, usual dosage note referencing the package insert, and warnings to keep out of reach of children. Distributed by Aurobindo Pharma USA, Inc., made in India.*

FDA Label Image

Chemical Structure1 (Amlo Val Str1)

Chemical structure of the active ingredients in Amlodipine and valsartan, showing molecular diagrams including aromatic rings, functional groups, and substituents such as chlorine (Cl) and sulfonic acid (SO3H) groups.*

FDA Label Image

Chemical Structure2 (Amlo Val Str2)

Chemical structure of amlodipine as part of the combination drug amlodipine and valsartan, showing detailed atomic arrangement with carbon, hydrogen, nitrogen, and oxygen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.